Bowel Research UK, a leading charity that funds research into bowel cancer and other bowel diseases, has announced the appointment of Lindsay Easton as its new Chief Executive Officer. Easton officially began her role on Wednesday, May 1, 2024.
She takes over from Lynn Dunne, who has been in the position since December 2021. Dunne will continue to work with the charity until her retirement at the end of June 2024 to ensure a smooth transition.
Easton brings over 25 years of experience in the charity sector, including six years as CEO for Brain Research UK. She has also held senior fundraising and marketing roles at organizations such as Action for Children, Amnesty International Australia, and Diabetes UK.
In her new role, Easton will work closely with the Board of Trustees to define Bowel Research UK’s strategic direction for the next five years. She expressed her excitement to join the charity and her determination to continue its success in funding innovative research.
Bowel Research UK’s outgoing CEO, Lynn Dunne, praised the charity’s achievements under her leadership, including successful fundraising campaigns and support for early career researchers.
Asha Senapati, Chair of Bowel Research UK, expressed her enthusiasm for Easton’s appointment and her confidence in her ability to drive the charity’s impact and fundraising efforts.
Bowel Research UK is dedicated to funding life-changing research into bowel cancer and other bowel diseases. With over 16,000 deaths from bowel cancer and over a million individuals suffering from bowel diseases in the UK every year, the charity’s work is crucial in saving and improving lives. For more information, visit https://www.bowelresearchuk.org/.
This news release was distributed by https://pressat.co.uk/.
